Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.

Intellia's Phase 3 trial for NTLA-2002 shows promise, but limitations warrant caution. See why we believe NTLA stock is hold ...

In the lower limbs, poor blood flow, slow healing, and nerve damage (neuropathy) can result in diabetic foot ulcers ... half ...

AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) ...

AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...

But the good news is, getting tested is usually quick, easy, and painless. And STDs can be cured or treated. Planned Parenthood health centers offer STD testing and treatment, and our caring and ...

This series of movies sees a child accidentally left behind by their family during Christmas to fend for themselves against burglars.

NABH and RSSDI sign a pact to enhance diabetes care in India through robust clinical and digital health standards. The ...

Medical expenses due to dizziness amount to about 550 billion won per year, and medical expenses spent every time a patient ...

New research describes how sphingolipids can also contribute to arterial plaques and atherosclerosis, revealing a new side to ...